ClinConnect ClinConnect Logo
Search / Trial NCT06493175

The Application of Large Language Model in Emergency Chest Pain Triage

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Jul 8, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Large Language Model Chest Pain

ClinConnect Summary

This clinical trial is looking at how well a special computer program, called a large language model, can help doctors quickly and accurately assess patients who come to the emergency room with chest pain. The goal is to see if this technology can improve the way patients are triaged, which means determining how urgently they need care.

To be eligible to participate, you must be at least 18 years old and experiencing chest pain when you arrive at the emergency department. However, some people won't be able to join, such as those with serious health issues or those who are unable to communicate. If you decide to participate, you can expect to help researchers understand how this technology can assist in emergency situations. Your involvement could contribute to better care for future patients with similar symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. All patients with chest pain entered the emergency triage procedure.
  • 2. patients aged 18 and above.
  • Exclusion Criteria:
  • 1. Patients with severe cognitive impairment or inability to communicate.
  • 2. There are patients who have been explicitly referred to specific departments (for example, some of the 120 transfer patients, who may go directly to the green channel) .
  • 3. Patients with unstable vital signs .
  • 4. Patients with potential medical problems.
  • 5. Is participating in other clinical trials.
  • 6. Failure to follow test procedures.
  • 7. Those who refuse to sign the informed consent form.

About Peking University Third Hospital

Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Yi-Da Tang, MD, PhD

Principal Investigator

Peking University Third Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported